rs4307059 — CDH9/CDH10

Intergenic variant at 5p14.1 between neuronal cell-adhesion genes CDH9 and CDH10, associated with autism spectrum disorder risk and related social-communication and sleep phenotypes

See your personal result for CDH9/CDH10

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

5p14.1 — The Social Brain Adhesion Locus

Between the two type-II classical cadherin genes CDH9 and CDH10 on chromosome 5p14.1 lies one of the most replicated common variant associations with autism spectrum disorder (ASD). The rs4307059 C allele was the lead signal from the first genome-wide significant common variant discovery in autism11 first genome-wide significant common variant discovery in autism
Wang K et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature, 2009, a landmark study that fundamentally changed how the genetics of social cognition was understood.

CDH9 and CDH10 encode [type-II neuronal cadherins | Classical cadherins are calcium-dependent cell-adhesion proteins that mediate cell-cell recognition; type-II cadherins are brain-enriched and guide synapse specificity during circuit assembly] — a family of calcium-dependent cell-adhesion molecules critical for establishing precise synaptic connections during brain development. Unlike structural cadherins in epithelial tissue, CDH9 and CDH10 are expressed in specific neuronal populations and act as molecular "zip codes" that help matching pre- and post-synaptic neurons recognize one another during circuit formation.

The Mechanism

The rs4307059 variant sits in an intergenic region between CDH9 and CDH10 and is classified as intronic within the uncharacterized locus LOC124901176. It does not alter the amino acid sequence of either cadherin. Instead, it is believed to function as a [regulatory element | A DNA sequence that controls when, where, and how much a nearby gene is expressed — can be an enhancer, silencer, or insulator] influencing the expression levels or timing of CDH10 or CDH9 during fetal brain development.

Wang et al. (2009) showed by [in situ hybridization | A technique that detects the location of specific mRNA molecules in tissue sections, showing where a gene is active] that CDH10 is expressed with marked enrichment in the orbitofrontal cortex and frontal cortex — precisely the regions implicated in social cognition, executive function, and Theory of Mind. Crucially, the study found that SNP genotypes at rs4307059 were not associated with CDH9 or CDH10 transcript levels in cortical brain tissue from adults, pointing toward a developmental window during fetal synaptogenesis when the regulatory effect is most relevant.

Neuronal cadherin-mediated adhesion is also central to [GABAergic interneuron | Inhibitory neurons that use GABA as their neurotransmitter; they fine-tune excitatory activity and are essential for cortical circuit balance] circuit assembly. Type-II cadherins guide the laminar positioning of interneuron populations during cortical development, and disruptions in this process have been mechanistically linked to both the excitatory- inhibitory imbalance observed in ASD and to sleep architecture disturbances — since GABAergic circuits regulate both social behavior and NREM sleep oscillations.

The Evidence

The original Wang et al. (2009) study22 original Wang et al. (2009) study
Wang K et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature, 2009 examined 780 families (3,101 subjects) as a discovery cohort and independently replicated the signal in 1,204 affected individuals and 6,491 controls — all of European ancestry. Six SNPs between CDH10 and CDH9 reached genome-wide significance, with rs4307059 as the lead signal (OR = 1.19, p = 3.4×10⁻⁸). The combined analysis across all cohorts reached p = 2.1×10⁻¹⁰, making this the first genome-wide-significant common variant finding in autism research.

The effect size is modest (OR = 1.19 per C allele), consistent with the highly polygenic architecture of ASD. The C allele is common in European populations (~38%) and rarer in African populations (~7%), which affects population-specific risk estimates substantially.

A large Swedish twin study Jonsson et al. (2014)33 Jonsson et al. (2014)
Jonsson L et al. Association study between autistic-like traits and polymorphisms in the autism candidate regions RELN, CNTNAP2, SHANK3, and CDH9/10. Mol Autism, 2014 of 12,319 children did not replicate the association with autistic-like traits in the general population. This non-replication is informative: it suggests that rs4307059's effect is specific to the clinical ASD phenotype (or its more severe end) rather than continuously distributed social traits across the population. This is a common finding for neuropsychiatric common variants — they reach significance in case- control ASD studies but show no measurable association with trait variation in unselected samples.

Practical Context

Sleep disturbances affect 40–80% of individuals with ASD, representing one of the most consistent and impactful co-occurring features. The biological link between CDH9/CDH10 circuit assembly and sleep is indirect but mechanistically grounded: frontal and orbitofrontal cortical circuits, where CDH10 is most enriched, regulate the GABAergic interneuron networks that orchestrate NREM sleep spindles and slow waves. Disrupted cadherin-mediated synaptogenesis in these circuits may produce both the social-cognitive and sleep phenotypes observed in ASD.

The C allele at rs4307059 confers a modest increase in ASD risk, and among people diagnosed with ASD, proactive management of sleep is the most actionable implication. Sleep disturbances amplify sensory sensitivity, reduce frustration tolerance, and worsen executive function — all areas directly affected by the frontal circuit dysfunction associated with this locus.

Interactions

The 5p14.1 locus at rs4307059 was originally positioned alongside CNTNAP2 (rs7794745) and SHANK3 variants as part of the neuronal cell-adhesion and synaptic scaffolding network implicated in ASD. While CNTNAP2 (chr7q35) and CDH9/CDH10 (chr5p14.1) are on different chromosomes and act through distinct synaptic mechanisms, they converge on the same developmental outcome: assembly of cortical inhibitory circuits during a critical window of fetal neurogenesis. Individuals carrying risk alleles at both loci may have compounding disruption to this circuit assembly process, though published interaction studies specifically testing rs4307059 × CNTNAP2 combinations are lacking.

Genotype Interpretations

What each possible genotype means for this variant.

TT Low ASD-Risk Allele Normal

No elevated autism-risk signal from this 5p14.1 locus

You carry two copies of the T allele, the common reference allele at this position. Your CDH9/CDH10 regulatory region does not carry the variant associated with elevated autism risk in large GWAS studies.

About 43% of people globally share this genotype, making it approximately equally common as the heterozygous CT genotype. In African-ancestry populations TT is far more prevalent (~86%) since the C allele is rare in African genomes.

CT One ASD-Risk Allele Intermediate

One copy of the 5p14.1 autism-risk allele — modest elevated risk

The 5p14.1 locus is one of a handful of common-variant loci that have reached genome-wide significance for ASD in European-ancestry cohorts. The effect size (OR 1.19 per allele) is modest but consistent across independent replication cohorts. Carrying one C allele raises your individual ASD risk polygenic contribution slightly above average.

More practically relevant for most CT carriers is the sleep dimension. Sleep disturbances are among the most common and functionally impairing features of ASD, affecting 40–80% of diagnosed individuals. The frontal and orbitofrontal cortical circuits where CDH10 is enriched play a key role in NREM sleep regulation through their GABAergic connections. Any disruption to circuit assembly in these regions — even subtle, sub-clinical disruption — can affect sleep architecture without meeting ASD diagnostic criteria.

If you or a family member has been evaluated for or diagnosed with ASD, the frontal circuit sleep link provides a specific mechanism for addressing sleep disturbances that go beyond standard sleep hygiene.

CC Homozygous ASD-Risk Allele High Risk

Two copies of the 5p14.1 autism-risk allele — highest genetic contribution from this locus

The two-copy C genotype sits at the high end of the risk distribution for this locus. In the Wang et al. 2009 discovery and replication cohorts, the signal was strongest in individuals of European ancestry, where CC homozygotes would be overrepresented in ASD cases.

The mechanistic pathway flows through CDH9/CDH10 expression in frontal and orbitofrontal cortex during fetal synaptogenesis. CDH10 shows marked expression enrichment in these regions based on in situ hybridization data, and the frontal cortex is central to social cognition, executive function, and — through its GABAergic projections to thalamus and brainstem — sleep spindle generation and slow wave activity.

Sleep disturbances are one of the most prevalent and impactful co-occurring features in individuals with ASD. Among ASD-diagnosed CC carriers, addressing sleep proactively can meaningfully improve daytime function, sensory tolerance, and adaptive behavior.

For CC carriers without an ASD diagnosis, this result suggests a genetic architecture leaning toward the frontal-circuit end of the neurodevelopmental spectrum. Subclinical sensory sensitivities, social communication style differences, or sleep difficulties may be worth exploring in clinical context.